Portsmouth Technologies has sold 30 lakh shares of Anthem Biosciences through a block deal valued at Rs 250 crore. The transaction represents a sizeable share sale involving the biotechnology company, although details about the buyer were not provided.
Deal details
The disclosed transaction includes two key figures: 30 lakh Anthem Biosciences shares were sold, and the deal carried a total value of Rs 250 crore. The sale was conducted as a block deal, a format used for large share transactions executed separately from regular market activity.
What the disclosure shows
The deal identifies Portsmouth Technologies as the selling shareholder and places the value of its share sale at Rs 250 crore. However, no further information was provided on the identity of the purchaser, the ownership stake represented by the shares, or the reason behind the transaction.
The available details also do not indicate how the deal may affect Anthem Biosciences’ ownership structure or provide any information about the company’s future plans. For now, the disclosed facts are limited to the size and value of the share sale.
Key takeaway
The Anthem Biosciences block deal marks a Rs 250 crore share sale by Portsmouth Technologies, involving 30 lakh shares. Additional transaction details were not available.